Skip to main content
. 2016 Jul 1;10:2129–2136. doi: 10.2147/DDDT.S105441

Table 2.

Response among patients with locally advanced ESCC to first-line treatment

Response Group A (n=105) Group B (n=97) Total (n=202)
CR (%) 18 (17.1) 7 (7.2) 25 (12.4)
PR (%) 37 (35.2) 30 (30.9) 67 (33.2)
SD (%) 46 (43.8) 55 (56.7) 101 (50.0)
PD (%) 4 (3.8) 5 (5.2) 9 (4.5)

Abbreviations: CR, complete response; ESCC, esophageal squamous cell carcinoma; PD, progressive disease; PR, partial response; SD, stable disease.